Original ArticleAntiretroviral Therapy for HIV-2 Infected Patients
References (26)
- et al.
Nine-year HIV-2-associated mortality in an urban community in Bissau, West Africa
Lancet
(1997) - et al.
Rapid and automatedtetrazolium-based colorimetric assay for the detection of anti-HIV compounds
J Virol Methods
(1988) - et al.
Systematicclassification of HIV biological subtypes on lymphocytes andmoncytes/macrophages
Virology
(1990) Comm Dis Rep
(1998)- et al.
HIV-2 infection in 12 European residents: virus characteristics and disease progression
AIDS
(1996) - et al.
HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4] lymphopenia in HIV type 2-infected individuals
AIDS Res Hum Retrovir
(1994) - et al.
Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection
AIDS
(1992) - et al.
Cellular and plasma viral load in patients infected with HIV-2
AIDS
(1993) - et al.
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection
J Hum Virol
(1998) - et al.
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology
J Virol
(1994)
HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau
AIDS Res Hum Retroviruses
(1997)
Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype
J Virol
(1998)
A comprehensive set of sequence analysis programs for the VAX
Nuc Acids Res
(1984)
Cited by (44)
Zero CD4 count: A case of discordant CD4 response in a patient with well suppressed viral load
2013, Indian Journal of Medical MicrobiologyBaseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso
2010, Transactions of the Royal Society of Tropical Medicine and HygieneStructural Evidence for Effectiveness of Darunavir and Two Related Antiviral Inhibitors against HIV-2 Protease
2008, Journal of Molecular BiologyEpidemiology, Natural History and Treatment of HIV-2 Infections
2008, Global HIV/AIDS MedicineEpidemiology, Natural History and Treatment of HIV-2 Infections
2007, Global HIV/AIDS Medicine
- f2
Current affiliation of Dr Berry: Division of Retrovirology, National Institute for Biological Standards and Control Potters Bar, Hertfordshire EN6 3QG, UK.
- f1
Please address all correspondence to: J. Breuer, Dept of Microbiology and Virology, The London and St Bartholomew's Hospital Trust, 37 Ashfield Street, E1 1BB, UK.
Copyright © 2001 The British Infection Society. Published by Elsevier Ltd. All rights reserved.